Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T Beissbarth
Strong EGFR Signaling in Cell Line Models of ERBB2-amplified Breast Cancer Attenuates Response Towards ERBB2-targeting Drugs
Oncogenesis
Cancer Research
Molecular Biology
Related publications
AKT Signaling in ERBB2-amplified Breast Cancer
Pharmacology and Therapeutics
Pharmacology
Novel Peptide/Protein Delivery System Targeting erbB2-Overexpressing Breast Cancer Cells
Novel Peptide/Protein Delivery System Targeting erbB2-Overexpressing Breast Cancer Cells
Conditional Knockout of SHP2 in ErbB2 Transgenic Mice or Inhibition in HER2-amplified Breast Cancer Cell Lines Blocks Oncogene Expression and Tumorigenesis
Oncogene
Cancer Research
Genetics
Molecular Biology
ErbB2 Regulation of C-SRC Activity in Breast Cancer
Role of Integrin Alpha 5 in ErbB2-Mediated Breast Cancer
An Insertion Mutation of ERBB2 Enhances Breast Cancer Cell Growth and Confers Resistance to Lapatinib Through AKT Signaling Pathway
Biology Open
Biochemistry
Agricultural
Genetics
Molecular Biology
Biological Sciences
Combining Lapatinib (GW572016), a Small Molecule Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, With Therapeutic Anti-ErbB2 Antibodies Enhances Apoptosis of ErbB2-overexpressing Breast Cancer Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
Preexisting Oncogenic Events Impact Trastuzumab Sensitivity in ERBB2-amplified Gastroesophageal Adenocarcinoma
Journal of Clinical Investigation
Medicine
